Dr. Alan Helfman Urologist Millburn NJ

Meet Alan S. Helfman, MD

Medical School

Universidad Autonoma de Guadalajara – Mexico

Internship & Residency

Rutgers New Jersey Medical School – Newark, NJ

Languages Spoken

English, Spanish

Ages Served

18+

Dr. Alan Helfman has more than 30 years of experience practicing urology. During the duration of his practice, he has honed his skills in numerous urologic procedures, including prostatectomy (prostate removal by surgery, laser or minimally invasive procedures), kidney stones, bladder cancer, vasectomy, endoscopy and many other urological conditions.

Dr. Helfman completed his medical training at the Universidad Autonoma de Guadalajara after finishing his undergraduate studies at the State University of New York at Buffalo where he obtained bachelor’s degree in biology and mathematics. He subsequently obtained a master’s degree from Roswell Park Memorial Cancer Institute. He completed his surgical and urological residency at the Rutgers New Jersey Medical School and brought his urological practice to Essex County in 1988.

Dr. Helfman is past president of Newark Beth Israel Medical Center and has been a member of the Board of Trustees for both the Saint Barnabas Healthcare System and Newark Beth Israel Medical Center. He currently serves as Chairman of the Newark Beth Israel Physician Hospital Association.

Dr. Helfman has co-authored numerous journal articles on prostate cancer therapy and received the Gloria Gallo Award for cancer research in 2001. In 2007, he was voted a New Jersey Top Doctor and has been named a Millburn-Short Hills Magazine Top Doctor in 2014, 2015, 2016, 2017, and 2018.

SPECIALTIES

  • Bladder Cancer
  • Cystoscopy
  • Kidney Stones
  • Men’s Health
  • Prostatectomy (removal of the prostate)
  • Vasectomy

MILLBURN

225 Millburn Avenue
Building C, Suite 304
Millburn, NJ 07041

P. (973) 218-9400

  • American Medical Association
  • American Urology Association
  • Medical Society of New Jersey
  • Essex County Medical Society
  • Academy of Medicine of New Jersey
  • New York Academy of Medicine
  • Urology Society of New Jersey
  • New York Section of American Urology Association
  • Essex County Health Organization
  • Metro West IPA
  • Metro Essex IPA
  • Newark Beth Israel Physician Hospital Organization
  • Saint Barnabas Physician Partnership
  • Dose Optimization for Prostate Cancer Brachytherapy Based on Magnetic Resonance Imaging Volume Studies: A New Technique (R. Ivker, G. Varsos, L. Coia
  • Accepted for Poster Presentation at the 1999 Annual Retreat on Cancer Research in New Jersey, New Brunswick, NJ, May 1999
  • High Dose Rate Radiation for Prostate Cancer Patients at High Risk for Failure: A New Treatment Option (R. Ivker, G. Varsos, S. Shoengold, et al)
  • Accepted for Oral Presentation at the 2000 Symposium on Clinical Cancer Research in New Jersey, West Orange, NJ March 2000.
  • Phase I/II Study for the Treatment of Patients with High Risk Prostate Cancer: A Preliminary Analysis (R. Ivker, G. Varsos, S. Shoengold, et al)
  • Accepted Oral Presentation at the 10th International Brachytherapy Conference, Madrid, Spain, November 2000
  • Preliminary Results of Combination External Beam Radiation Therapy Plus High Dose Rate Brachytherapy in High Risk Prostate Cancer Patients: An Evaluation of Acute GI Toxicity (R. Ivker, G. Varsos, S. Shoengold, et al)
  • Accepted for Oral Presentation at the MITRE 2000 meeting of ESTRO, Brussels, Belgium, December 2000.
  • Patterns and Predictions of Acute Toxicity after HDR Brachytherapy and 3D CRT for Localized Prostate Cancer: Preliminary Results of a Phase I-II Dose Escalation Trial (A. Raben, A. Grebler, R. Ivker, J. Geltzeiler, et al)
  • Gallo Award – Presented at 2001 Annual Retreat on Cancer Research in New Jersey (The Cancer Institute of New Jersey)
  • Accepted for Oral Presentation at the co-joint meeting of the American Brachytherapy Society Meeting and Canadian Brachytherapy Group, Vancouver, British Columbia, Canada, May 2001
  • Accepted for submittal into syllabus at the First International Prostate Cancer Congress, San Juan, Puerto, June 2001
  • Accepted for Poster Presentation at the 43rd Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Francisco, CA, November 2001
  • Subset Analysis of Patients with Highest Risk Non-metastatic Prostate Cancer Treated with Hormonal Ablation, External Beam Radiation Therapy, and High Dose rate Radiation (R. Ivker, et al)
  • Accepted Presentation at 87th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago, IL, November 2001
  • A Phase I/II Study for the Treatment of Patients with Recurrent Nonmetastatic Prostate Cancer: A New Treatment Option (R. Ivker, A. Sacher, A. Helfman, et al)
  • Accepted Presentation at 11th International Brachytherapy Conference, Santa Fe, New Mexico, June 2002
  • Patterns and Predictors of Acute Toxicity After HDR Brachytherapy and 3D-CRT for Localized Prostate Cancer: Preliminary Results of Phase I-II Dose Escalation Study
  • Accepted Presentation at 11th International Brachytherapy Conference, Santa Fe, New Mexico 2002
  • A Phase I/III Study for the Treatment of Patients with Recurrent, Non-metastatic Prostate Cancer: A New Treatment Option (R. Ivker, A. Sacher, A. Helfman, et al)
  • Accepted for Poster Presentation at the American Brachytherapy Society Meeting, New York, NY, May 2003
  • Subset Analysis of Highest Risk Prostate Cancer Patients Treated with Hormonal Ablation, External Radiation Therapy and Dose-Escalating High Dose Rate Brachytherapy (R. Ivker, A. Helfman, S. Shoengold, A. Strumeyer, et al)
  • Accepted for Poster Presentation at the 86th Annual Meeting of the American Radium Society, Napa Valley, CA, May 1-5, 2004
  • Boy Scouts Distinguished Healthcare Award (2017)
  • Millburn Short Hills Magazine Top Doctor (2014-2018)
  • New Jersey Magazine Top Doctor (2007)
  • Gallo Award for Cancer Research, The Cancer Institute of New Jersey (2001)
  • American Medical Association Physician’s Recognition Award (2014-2017)
  • American Medical Association Physician’s Recognition Award (2011-2014)
  • American Medical Association Physician’s Recognition Award (2008-2011)
  • American Medical Association Physician’s Recognition Award (2005-2008)
  • American Medical Association Physician’s Recognition Award (2002-2005)
  • American Medical Association Physician’s Recognition Award (1999-2002)
  • American Medical Association Physician’s Recognition Award (1996-1999)
  • American Medical Association Physician’s Recognition Award (1993-1996)
  • American Medical Association Physician’s Recognition Award (1990-1993)
  • Newark Beth Israel Medical Center
  • Saint Barnabas Medical Center
  • The Stone Center of New Jersey
  • Aetna
  • CHN
  • Cigna
  • Clover
  • Horizon Blue Cross Blue Shield of NJ
  • Emblem Health
  • Empire Blue Cross HMO (Contiguous County only)
  • Empire Blue Cross PPO
  • GHI
  • HealthNet Federal
  • Humana
  • Magnacare
  • Medicare
  • Multiplan
  • Oxford
  • Qualcare
  • Railroad Medicare
  • Tricare
  • UnitedHealthcare (excluding Medicare Plans)
  • US Family Health